Onderneming Monte Rosa Therapeutics, Inc.
Aandelen
GLUE
US61225M1027
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,63 USD | +1,97% |
|
-5,22% | -35,75% |
Vakgebied
Aantal werknemers: 130
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 01-01-20 |
Chief Operating Officer | - | 01-03-21 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-06-21 |
Sharon Townson
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-07-20 |
John Castle
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-05-20 |
Philip Nickson
LAW | General Counsel | 45 | 01-03-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 01-09-20 |
Christine Siu
BRD | Director/Board Member | 47 | 01-12-20 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 01-09-20 |
Ali Behbahani
BRD | Director/Board Member | 45 | 01-04-20 |
Anthony Manning
BRD | Director/Board Member | 62 | 25-07-23 |
Markus Warmuth
CEO | Chief Executive Officer | 53 | 01-01-20 |
Jan Skvarka
BRD | Director/Board Member | 57 | 23-03-23 |
Director/Board Member | 55 | 01-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 60 848 785 | 60 405 481 ( 99,27 %) | 10 005 ( 0,0164 %) | 99,27 % |
Bedrijfsgegevens
![Adres Monte Rosa Therapeutics, Inc.(GLUE)](https://cdn.zonebourse.com/static/address/124047172.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,75% | 222 mln. | |
+34,14% | 51,12 mld. | |
-6,54% | 39,4 mld. | |
+34,92% | 38,48 mld. | |
+12,62% | 26,36 mld. | |
-12,11% | 26,22 mld. | |
-13,43% | 20,96 mld. | |
+43,73% | 14,02 mld. | |
+31,81% | 12,49 mld. | |
-4,54% | 11,61 mld. |
- Beurs
- Aandelen
- Koers GLUE
- Onderneming Monte Rosa Therapeutics, Inc.